Top

International Journal of Clinical Oncology

Published in:

01-12-2018 | Original Article

Cardiac output response to exercise in patients before allogenic hematopoietic stem cell transplantation

Authors: Shinya Yoshida, Fujiko Someya, Tetsutaro Yahata

Published in: International Journal of Clinical Oncology | Issue 6/2018

Abstract

Introduction

High-dose chemotherapy for remission induction can induce cardiac toxicity prior to hematopoietic stem cell transplantation (HSCT). However, the details of cardiac function in patients undergoing HSCT are unclear, particularly during exercise. The aim of present study was to evaluate cardiac output responses to exercise in patients after high-dose chemotherapy before HSCT compared with in age-matched healthy controls.

Methods

Twenty-nine patients before HSCT (age 44.6 ± 15.2 years) and 13 controls (45.8 ± 16.0 years) performed the 6-min walk test (6MWT). Cardiac output (CO), stroke volume (SV), heart rate (HR), and cardiac index (CI) were continuously measured during the 6MWT using the noninvasive thoracic impedance method.

Results

No significant difference was observed in the six-minute walk distance (6MD) between the two groups. SV, CO, and CI both at rest and the end of the 6MWT in the patients were significantly lower, compared with the controls, but there was no significant difference in HR. In all subjects, the 6MD was positively correlated with SV, CO, CI, and HR after the 6MWT.

Conclusion

These findings suggest that cardiac output response to exercise indicates exercise intolerance, which may not be detected by 6MD in patients before HSCT.

Fujimaki K, Maruta A, Yoshida M et al (2001) Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction. Bone Marrow Transpl 27(3):307–310. https://doi.org/10.1038/sj.bmt.1702783 CrossRef

Qazilbash MH, Amjad AI, Qureshi S et al (2009) Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction. Biol Blood Marrow Transpl 15(10):1265–1270. https://doi.org/10.1016/j.bbmt.2009.06.001 CrossRef

Hurley P, Konety S, Cao Q et al (2015) Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done? Biol Blood Marrow Transpl 21(2):300–304. https://doi.org/10.1016/j.bbmt.2014.10.011 CrossRef

Scott JM, Armenian S, Giralt S et al (2016) Cardiovascular disease following hematopoietic stem cell transplantation: pathogenesis, detection, and the cardioprotective role of aerobic training. Crit Rev Oncol Hematol 98:222–234. https://doi.org/10.1016/j.critrevonc.2015.11.007 CrossRefPubMed

Kelsey CR, Scott JM, Lane A et al (2014) Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study. Bone Marrow Transpl 49(10):1330–1336. https://doi.org/10.1038/bmt.2014.159 CrossRef

Wood WA, Deal AM, Reeve BB et al (2013) Cardiopulmonary fitness in patients undergoing hematopoietic SCT: a pilot study. Bone Marrow Transpl 48(10):1342–1349. https://doi.org/10.1038/bmt.2013.58 CrossRef

American Thoracic Society (2002) ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166:111–117. https://doi.org/10.1164/rccm.166/1/111 CrossRef

Richard RL-WE, Charloux A et al (2001) Non-invasive cardiac output evaluation during a maximal progressive exercise test, using a new impedance cardiograph device. Eur J Appl Physiol 85:202–207CrossRef

Anne CEL, Ruddy R (2000) A new impedance cardiograph device for the non-invasive evaluation of cardiac output at rest and during exercise: comparison with the “direct” Fick method. Eur J Appl Physiol 82:313–320CrossRef

10.

Someya F, Mugii N, Oohata S (2015) Cardiac hemodynamic response to the 6-minute walk test in young adults and the elderly. BMC Res Notes 8:355. https://doi.org/10.1186/s13104-015-1331-5 CrossRefPubMedPubMedCentral

11.

Someya F, Mugii N, Oohata S (2016) Factors relating to impaired stroke volume during the 6-minute salk test in patients with systemic sclerosis. Clin Exp Rheumatol 34:152–156PubMed

12.

Kanda Y (2013) Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transpl 48(3):452–458. https://doi.org/10.1038/bmt.2012.244 CrossRef

13.

Sakata-Yanagimoto M, Kanda Y, Nakagawa M et al (2004) Predictors for severe cardiac complications after hematopoietic stem cell transplantation. Bone Marrow Transpl 33(10):1043–1047. https://doi.org/10.1038/sj.bmt.1704487 CrossRef

14.

Sucak GT, Ozkurt ZN, Aki Z et al (2008) Cardiac systolic function in patients receiving hematopoetic stem cell transplantation: risk factors for posttransplantation cardiac toxicity. Transpl Proc 40(5):1586–1590. https://doi.org/10.1016/j.transproceed.2007.11.077 CrossRef

15.

Morandi P, Ruffini PA, Benvenuto GM et al (2005) Cardiac toxicity of high-dose chemotherapy. Bone Marrow Transpl 35(4):323–334. https://doi.org/10.1038/sj.bmt.1704763 CrossRef

16.

Blaes A, Konety S, Hurley P (2016) Cardiovascular complications of hematopoietic stem cell transplantation. Curr Treat Opt Cardiovasc Med. https://doi.org/10.1007/s11936-016-0447-9 CrossRef

17.

Steinberg A, Asher A, Bailey C et al (2015) The role of physical rehabilitation in stem cell transplantation patients. Support Care Cancer 23:2447–2460CrossRef

18.

Morishita S, Kaida K, Ikegame K et al (2012) Impaired physiological function and health-related QOL in patients before hematopoietic stem-cell transplantation. Support Care Cancer 20(4):821–829. https://doi.org/10.1007/s00520-011-1156-2 CrossRefPubMed

19.

White ACTN, Miller KB, Ryan HF (2005) Impaired respiratory and skeletal muscle strength in patients prior to hematopoietic stem-cell transplantation. Chest 128:145–152CrossRef

20.

Casanova C, Celli BR, Barria P et al (2011) The 6-min walk distance in healthy subjects: reference standards from seven countries. Eur Respir J 37(1):150–156. https://doi.org/10.1183/09031936.00194909 CrossRefPubMed

21.

Fukuda T, Matsumoto A, Kurano M et al (2012) Cardiac output response to exercise in chronic cardiac failure patients. Int Heart J 53(5):293–298CrossRef

22.

Abudiab MM, Redfield MM, Melenovsky V et al (2013) Cardiac output response to exercise in relation to metabolic demand in heart failure with preserved ejection fraction. Eur J Heart Fail 15(7):776–785. https://doi.org/10.1093/eurjhf/hft026 CrossRefPubMedPubMedCentral

23.

Dhakal BP, Malhotra R, Murphy RM et al (2015) Mechanisms of exercise intolerance in heart failure with preserved ejection fraction: the role of abnormal peripheral oxygen extraction. Circ Heart Fail 8(2):286–294. https://doi.org/10.1161/CIRCHEARTFAILURE.114.001825 CrossRefPubMed

24.

Haykowsky MJ, Brubaker PH, John JM et al (2011) Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol 58(3):265–274. https://doi.org/10.1016/j.jacc.2011.02.055 CrossRefPubMedPubMedCentral

25.

Cardinale D, Sandri MT, Martinoni A et al (2000) Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy. J Am Coll Cardiol 36(2):517–522CrossRef

Title: Cardiac output response to exercise in patients before allogenic hematopoietic stem cell transplantation
Authors: Shinya Yoshida
Fujiko Someya
Tetsutaro Yahata
Publication date: 01-12-2018
Publisher: Springer Japan
Published in: International Journal of Clinical Oncology / Issue 6/2018
Print ISSN: 1341-9625
Electronic ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-018-1315-2

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Introduction

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 6/2018

Novel graded prognostic assessment for colorectal cancer patients with brain metastases

Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments

Analysis and treatment of 45 platinum-allergic gynecologic malignant tumors

Current situation of cancer among adolescents and young adults in Japan

List of reviewers 2017–2018

Definitive chemoradiotherapy for anal canal cancer: single-center experience

Keynote webinar | Spotlight on antibody–drug conjugates in cancer